FRANCOIS CEDRIC (Chief Executive Officer) received a stock award from APELLIS PHARMACEUTICALS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 1/30/2026ACC: 0001492422-26-000071
DirectorOfficer· Chief Executive Officer
Since Feb 2019
+195.95K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
195.95K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+195.95K
Price / share
—
Trade value
—
% of position
68.5%
1/28/2026
286.05K→482K
Total
Net shares
+195.95K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/28/2026 | A · Award | +195.95K | — | — | 68.5% | 286.05K | 482K |
| Total | +195.95K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)4
Common Stock
IndirectShares owned234.41K
Common Stock
IndirectShares owned307.95K
Common Stock
IndirectShares owned300K
Common Stock
IndirectShares owned472.06K
Total
1.31M indirect1.31M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 234.41K | Indirect |
| Common Stock | 307.95K | Indirect |
| Common Stock | 300K | Indirect |
| Common Stock | 472.06K | Indirect |
| Total | 1.31M | 1.31M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported